Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Strnad

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Brachytherapy|October 9, 2024
Definitive treatment for primary urethral cancer: A single institution's experience with organ-preserving brachytherapyR Merten, V Strnad, A Karius, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Protective effect of amifostine on dental health after radiotherapy of the head and neckV Rudat, J Meyer, F Momm, et al.
HNO|August 4, 2010
[Brachytherapy for the treatment of head and neck cancer]J E Meyer, C Brocks, S Maune, et al.
Plos One|September 22, 2017
A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patientsTh I Götz, G Lahmer, V Strnad, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 24, 2006
[High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study]L M Heindl, M Lotter, V Strnad, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 1997
[Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation]V Strnad, F Kamprad, J Jahns, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 24, 2005
[Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial]O J Ott, R Pötter, G Hildebrandt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 1996
[Reoxygenation in Yoshida sarcoma during different fractionated radiotherapy]V Strnad, F Kamprad, J Jahns, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 17, 2001
Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997G G Grabenbauer, C Rödel, T Brunner, et al.
Circulation|March 27, 2002
High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasmD Scheinert, V Strnad, R Müller, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Brachytherapy|October 9, 2024
Definitive treatment for primary urethral cancer: A single institution's experience with organ-preserving brachytherapyR Merten, V Strnad, A Karius, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2000
Protective effect of amifostine on dental health after radiotherapy of the head and neckV Rudat, J Meyer, F Momm, et al.
HNO|August 4, 2010
[Brachytherapy for the treatment of head and neck cancer]J E Meyer, C Brocks, S Maune, et al.
Plos One|September 22, 2017
A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patientsTh I Götz, G Lahmer, V Strnad, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|November 24, 2006
[High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study]L M Heindl, M Lotter, V Strnad, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 1, 1997
[Regression of Yoshida sarcoma during normoxia and hypoxia after fractionated irradiation]V Strnad, F Kamprad, J Jahns, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|June 24, 2005
[Partial breast irradiation for early breast cancer with favorable prognostic factors: 3-year results of the German-Austrian phase II-trial]O J Ott, R Pötter, G Hildebrandt, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 1, 1996
[Reoxygenation in Yoshida sarcoma during different fractionated radiotherapy]V Strnad, F Kamprad, J Jahns, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 17, 2001
Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997G G Grabenbauer, C Rödel, T Brunner, et al.
Circulation|March 27, 2002
High-dose intravascular beta-radiation after de novo stent implantation induces coronary artery spasmD Scheinert, V Strnad, R Müller, et al.
Pageof 8